TY  - GENERIC
DO  - 10.20944/preprints202006.0232.v1
UR  - http://dx.doi.org/10.20944/preprints202006.0232.v1
TI  - <sup></sup><strong>Repurposing of FDA Approved Drugs as COVID-19 Therapeutics: Safety Concerns and Contraindications of Drugs in Clinical Trials</strong>
T2  - Preprints
AU  - Dharavath, Ravinder Naik
AU  - Dutt, Meenu
AU  - Kumar, Sunil
AU  - Badyal, Priya
AU  - Rawat, Nitin
AU  - Kaur, Tanzeer
AU  - Sharma, Shweta
AU  - Bishnoi, Mahendra
AU  - Chopra, Kanwaljit
PY  - 2020
DA  - 2020/06/18
PB  - Preprints